Skip to main content
. 2022 Apr 19;66(2):229–236. doi: 10.20945/2359-3997000000457

Table 3. Characterization of CD presentation in patients with T1D.

Age at diagnosis of CD (years)
Mean 10,50
SD/Min-Max 2,65/7,0-13,0
Follow-up between T1D and CD diagnosis (years)
Mean 3,40
SD/Min-Max 3,32/0,08-7,25
HLA screening, n (%)
Registered 3 (75%)
HLA DQ2 1 (33,3%)
HLA DQ2/DQ8 2 (66,7%)
Positive IgA antibodies (at diagnosis), n (%)
Anti-EmA IgA 0 (0%)
Anti-tTG IgA 1 (33,3%)
Anti-EmA e Anti-tTG IgA 2 (66,7%)
Positive IgG antibodies (at diagnosis), n (%)
Anti-EmA e Anti-tTG IgG 100%, n = 1
Biopsy histology n (%)
3B 2 (50%)
3C 2 (50%)
GI symptoms n (%) 0 (0%)
Non-GI symptoms n (%) 4 (100%)
Poor weight gain 1 (25%)
Nail changes 1 (25%)
Iron deficient anemia 1 (25%)
Poor weight gain and hypoglycemia 1 (25%)